Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine conjunctival allergen challenge mast-cell stabilization study
2005-004768-22Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of olopatadine in seasonal allergic conjunctivitis (SAC) (2 arms), sponsored by Alcon Inc. Started Aug 2006; status: completed.
02
Drugs
olopatadine
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on 2005-004768-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004768-22.